News
A report on Alzheimer's disease. Click here to view the video featuring Sanders-Brown faculty.
The University of Kentucky has been awarded a prestigious Centers of Biomedical Research Excellence (COBRE) grant to study central nervous system metabolism from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH). The $10.6 million, five-year grant will fund UK’s Center of Research in Central Nervous System Metabolism (CNS-Met).
This story was originally published by WKYT here.
This Labor Day, WKYT-TV, is highlighting the world-class work going on at the University of Kentucky’s Sanders-Brown Center on Aging. The Lexington-based CBS affiliate will air a 30-minute special on their second station, The CW, at 6:30 p.m. Monday, Sept. 4.
A team of researchers at the University of Kentucky has found that a drug used to treat multiple sclerosis (MS) is potentially effective as a therapy for Alzheimer’s disease.
Alzheimer’s is a progressive and irreversible neurological disorder. It’s estimated 6.2 million Americans aged 65 and older are living with the disease that affects cognitive function, memory and behavior.
My name is Rohan Desai, and I am a third-year undergraduate student currently working in the lab Maj-Linda Selenica, PhD, to study the effects of TDP-43 proteinopathy in the multi-etiology of the Alzheimer’s Disease (AD), LATE, and FTD spectrum.
Anika Hartz, PhD, was recently promoted to professor in the UK College of Medicine Department of Pharmacology and Nutritional Sciences. The secret to her success is rooted in her love for science and pursuing groundbreaking discoveries.
Asked how she copes with the emotional side of her role in palliative care, Abigail Latimer, PhD, MSW, LCSW, puts it simply. “I want to be there for people on some of their hardest days.”
The University of Kentucky College of Medicine is excited to announce that faculty, staff, learners, and trainees will have free access to a leading online resource for medical Spanish proficiency.
My name is Panhavuth Phe and I am a recent neuroscience graduate from the UK College of Arts and Sciences and am also a graduate of the Lewis Honors College. I have received departmental honors from the UK College of Medicine Neuroscience Department and was recognized as the “Most Valuable Committee Member” for the 2022 NeuroW
LEXINGTON, Ky. (WKYT) - WKYT is continuing its in-depth look at the work of the Sanders-Brown Center on Aging. The organization, affiliated with the University of Kentucky, employs 125 people. One of them is an RN, and she’s gaining a reputation with her research participants.
A recent study from the lab of the University of Kentucky’s Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., has been published in PLOS ONE. The work centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease (AD). This study focused on a protein known as p38.
(LEX 18) — College students can find themselves on all kinds of interesting trips, but one group from Western Kentucky University is on an all-out adventure.
"We ride, usually, about 70, 75 miles a day and then from there, we get off the bike, get something to eat, go to sleep, wake up and do it all over again," said Trey Englehardt.
Na’Tasha Evans, PhD, MEd, is a researcher, published author, champion for female empowerment, and our new vice dean for diversity, equity, and inclusion at the University of Kentucky College of Medicine. Learn more about her goals, her past work, and more in the following Q&A.
On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer’s disease.
Congratulations to the following basic science and clinical faculty at the University of Kentucky College of Medicine! These individuals were honored with promotions and tenure in fiscal year 2023.
Names are organized alphabetically by department.
A researcher at the University of Kentucky will work to better understand the connection between posttraumatic stress disorder (PTSD) and dementia.
Healthy brain aging is a concern for all of us. June is recognized as Brain and Alzheimer’s Awareness Month. It’s normal to struggle with small things such as recalling names — and we all experience some slowing of the thought processes with advanced age — but everyone hopes to avoid serious cognitive impairment.
“A lot of people who have dementia do not have Alzheimer’s disease.” That is a statement that guides researchers at the University of Kentucky’s Sanders-Brown Center on Aging as they aim to better define other causes of dementia.